Pet-Mri Service With Psma 1007 Aimed At Detecting Clinically Significant Prostate Cancer In Men Carrying Mutations In The Brca Gene To Carry Out Project Pi23/01310, Led By The Biomedical Research Group In Urology Of The Vall Hebron University Hospital Foundation - Research Institute (Vhir), Financed By The Carlos Iii Health Institute (Isciii) And Co-Financed By The European Union Through Feder.

Fundacio Hospital Universitari Vall d'Hebron - Institut de Recerca Spain has Released a tender for Pet-Mri Service With Psma 1007 Aimed At Detecting Clinically Significant Prostate Cancer In Men Carrying Mutations In The Brca Gene To Carry Out Project Pi23/01310, Led By The Biomedical Research Group In Urology Of The Vall Hebron University Hospital Foundation - Research Institute (Vhir), Financed By The Carlos Iii Health Institute (Isciii) And Co-Financed By The European Union Through Feder. in Healthcare and Medicine. The tender was released on Aug 27, 2024.

Country - Spain

Summary - Pet-Mri Service With Psma 1007 Aimed At Detecting Clinically Significant Prostate Cancer In Men Carrying Mutations In The Brca Gene To Carry Out Project Pi23/01310, Led By The Biomedical Research Group In Urology Of The Vall Hebron University Hospital Foundation - Research Institute (Vhir), Financed By The Carlos Iii Health Institute (Isciii) And Co-Financed By The European Union Through Feder.

Deadline - Sep 10, 2024

GT reference number - 91491248

Product classification - Medical equipments, pharmaceuticals and personal care products